Substantia nigra depigmentation and exposure to encephalitis lethargica.
about
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient AutopsiesBrain pathologies in extreme old age.The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's DiseaseInflammation in neurodegenerative diseases--an update.Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report.
P2860
Substantia nigra depigmentation and exposure to encephalitis lethargica.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Substantia nigra depigmentation and exposure to encephalitis lethargica.
@en
type
label
Substantia nigra depigmentation and exposure to encephalitis lethargica.
@en
prefLabel
Substantia nigra depigmentation and exposure to encephalitis lethargica.
@en
P2093
P2860
P356
P1433
P1476
Substantia nigra depigmentation and exposure to encephalitis lethargica
@en
P2093
Annalisa Abell
Dawson Dean
Gregory A Jicha
Jerrold L Vitek
Joseph R Berger
P2860
P304
P356
10.1002/ANA.23697
P50
P577
2012-12-01T00:00:00Z